Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
Haibo Zhang et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Jasper Fuk-Woo Chan et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
Xintian Xu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
Yingxia Liu et al.
SCIENCE CHINA-LIFE SCIENCES (2020)
The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
Liang Chen et al.
CARDIOVASCULAR RESEARCH (2020)
COVID-19, Arrhythmic Risk, and Inflammation Mind the Gap!
Pietro Enea Lazzerini et al.
CIRCULATION (2020)
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin An Analysis of the World Health Organization Pharmacovigilance Database
Lee S. Nguyen et al.
CIRCULATION (2020)
High-Sensitivity Cardiac Troponin Can Be an Ally in the Fight Against COVID-19
Andrew R. Chapman et al.
CIRCULATION (2020)
COVID-19 and the Heart
Akbarshakh Akhmerov et al.
CIRCULATION RESEARCH (2020)
Initial COVID-19 affecting cardiac patients in China
Yaling Han
EUROPEAN HEART JOURNAL (2020)
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Riccardo M. Inciardi et al.
EUROPEAN HEART JOURNAL (2020)
COVID-19 and heart failure: from infection to inflammation and angiotensinIIstimulation. Searching for evidence from a new disease
Daniela Tomasoni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?
Jixiang Zhang et al.
HEART (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Cardiac and arrhythmic complications in patients with COVID-19
Adriano Nunes Kochi et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis
Long-quan Li et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Off-label use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers
Alexandre Gerard et al.
THERAPIE (2020)
Ramipril in High-Risk Patients With COVID-19
Ignacio J. Amat-Santos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Elissa Driggin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Francisco J. de Abajo et al.
LANCET (2020)
Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
Zou Xin et al.
FRONTIERS OF MEDICINE (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Shaobo Shi et al.
JAMA CARDIOLOGY (2020)
Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
Jin Liu et al.
EBIOMEDICINE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Speculation is not evidence: antihypertensive therapy and COVID-19
Giovanni de Simone et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2020)
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19
Mingyue Li et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Riccardo M. Inciardi et al.
EUROPEAN HEART JOURNAL (2020)
Epidemiology of cardiovascular disease in China: current features and implications
Dong Zhao et al.
NATURE REVIEWS CARDIOLOGY (2019)
MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
Waleed H. Mahallawi et al.
CYTOKINE (2018)
ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
Susana Cadenas
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Molecular Evolution of Human Coronavirus Genomes
Diego Forni et al.
TRENDS IN MICROBIOLOGY (2017)
Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis
Glaucia E. Callera et al.
BIOSCIENCE REPORTS (2016)
Targeting endoplasmic reticulum stress in hypoxia-induced cardiac injury
William Durante
VASCULAR PHARMACOLOGY (2016)
The role of hypoxia in inflammatory disease
John Biddlestone et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
Vaibhav B. Patel et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
The ACE2 gene: its potential as a functional candidate for cardiovascular disease
Louise M. Burrell et al.
CLINICAL SCIENCE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Role of curcumin on chloroquine phosphate-induced reproductive toxicity
Ketaki R. Desai et al.
DRUG AND CHEMICAL TOXICOLOGY (2012)
Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis
Daniel Caldeira et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Cardiovascular complications of severe acute respiratory syndrome
CM Yu et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury
K Kuba et al.
NATURE MEDICINE (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
The sympathetic nervous system and hypertension - Recent developments
GF DiBona
HYPERTENSION (2004)
Share Paper
